AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 262: R1064-R1069, 1992;
0363-6119/92 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Huysse, J. W.
Right arrow Articles by Bealer, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Huysse, J. W.
Right arrow Articles by Bealer, S. L.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 262, Issue 6 1064-R1069, Copyright © 1992 by American Physiological Society


ARTICLES

Central nervous system catecholamine content and norepinephrine release after AV3V ablation

J. W. Van Huysse and S. L. Bealer
Department of Physiology and Biophysics, University of Tennessee, Memphis 38163.

Electrolytic ablation of the periventricular tissue surrounding the anteroventral third cerebral ventricle (AV3V-X) results in immediate increases in norepinephrine release in the paraventricular hypothalamic nucleus/anterior hypothalamus (P/A) and in the dorsomedial medulla (DM) and depletion of norepinephrine and epinephrine throughout the brain. The present study determined whether catecholamine depletion and/or altered norepinephrine release persisted after recovery from the acute effects of AV3V-X. Fourteen to eighteen days after surgery, catecholamine concentrations throughout the brain and norepinephrine release in the P/A and DM during hemorrhage were measured in control-operated and AV3V-X rats. AV3V-X decreased epinephrine content only in the midbrain, increased norepinephrine only in the cortex, and produced no differences in central nervous system dopamine. Hemorrhage-induced norepinephrine release was significantly greater in the P/A of AV3V-X rats than in control animals, whereas norepinephrine release in the DM increased equally in both groups. Thus AV3V-X does not result in chronic global central nervous system catecholamine depletion and enhances norepinephrine release in the P/A during hemorrhage.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. L. Bealer and W. R. Crowley
Noradrenergic control of central oxytocin release during lactation in rats
Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E453 - E458.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. Haugan, M. Shalmi, J. S. Petersen, N. Marcussen, J. Spannow, and S. Christensen
Effects of Renal Papillary-Medullary Lesion on the Antihypertensive Effect of Furosemide and Development of Salt-Sensitive Hypertension in Dahl-S Rats
J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1415 - 1422.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. W. Cowley Jr, D. L. Mattson, S. Lu, and R. J. Roman
The Renal Medulla and Hypertension
Hypertension, April 1, 1995; 25(4): 663 - 673.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online